Major Asthma Treatment Shock: Doctors Reach for OCS over Biologics - Here's Why!

A recent study published in the Journal of Asthma and Allergy has revealed a surprising trend in the treatment of asthma, leaving many patients and medical professionals alike reeling from the results. It appears that maintenance Oral Corticosteroids (OCS) are being used more frequently than biologics in patients with severe asthma.

This finding is particularly notable given the recent surge in biologic treatments, which have been hailed as a major breakthrough in managing severe asthma. However, despite their growing popularity, biologics have not yet become the go-to treatment option for many doctors.

To understand why this might be the case, let's take a closer look at both treatment options. Oral Corticosteroids (OCS) have been a staple in asthma treatment for decades. They work by reducing inflammation in the airways, which can help to prevent asthma attacks. OCS are often prescribed as a maintenance medication to help manage symptoms and prevent exacerbations.

Biologics, on the other hand, are a relatively new class of medications that target specific proteins involved in inflammation. They are typically used to treat severe asthma that is not well-controlled with traditional medications, including OCS. Biologics have been shown to be highly effective in reducing symptoms and preventing exacerbations in many patients.

So why are doctors choosing OCS over biologics? One possible reason is that OCS are often less expensive than biologics, which can be a major factor in treatment decisions. Additionally, OCS have a long history of use and are well-established in clinical practice, which may contribute to their continued popularity.

Another possible explanation is that biologics may not be as widely available or accessible to all patients. Biologics often require specialized administration and monitoring, which can be a barrier to access in some areas. Furthermore, biologics may not be covered by all insurance plans, which can make them prohibitively expensive for some patients.

It's also worth noting that the study suggests that OCS may be being over-prescribed in some cases. While OCS can be effective in managing asthma symptoms, they can also have significant side effects, particularly with long-term use. These side effects can include weight gain, mood changes, and increased risk of osteoporosis and cataracts.

Ultimately, the decision to use OCS or biologics should be based on individual patient needs and circumstances. While OCS may be a good option for some patients, biologics may be more suitable for others. As with any medical treatment, it's essential to weigh the potential benefits and risks carefully and to work closely with a healthcare provider to determine the best course of treatment.